How Does TGF-β Mediate Tubulointerstitial Fibrosis?

Seminars in Nephrology

Volumn 32, Issue 3, 2012, Pages 228-235

  Gewin, Leslie ^a,b   Zent, Roy ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chronic kidney disease; Extracellular matrix; TGF ; Tubulointerstitial fibrosis

Indexed keywords

ABELSON KINASE; ALPHA SMOOTH MUSCLE ACTIN; BETA CATENIN; COLLAGEN TYPE 1; CYTOKINE; FIBRONECTIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; P21 ACTIVATED KINASE 2; PROTEIN ZO1; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VIMENTIN;

APOPTOSIS; ARTICLE; CELL DEDIFFERENTIATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; FIBROBLAST; HUMAN; INFLAMMATORY CELL; INTRACELLULAR SIGNALING; KIDNEY FIBROSIS; KIDNEY TUBULE CELL; MICROVASCULATURE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; TUBULOINTERSTITIAL FIBROSIS;

ACUTE KIDNEY INJURY; ENDOTHELIUM; EPITHELIUM; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY TUBULES; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84864128173     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2012.04.001     Document Type: Article

References (81)

1. Rifkin D.B. Latent transforming growth factor-beta (TGF-beta) binding proteins: orchestrators of TGF-beta availability. J Biol Chem 2005, 280:7409-7412.
2. Jenkins G. The role of proteases in transforming growth factor-beta activation. Int J Biochem Cell Biol 2008, 40:1068-1078.
3. Wrana J.L., Attisano L., Carcamo J., Zentella A., Doody J., Laiho M., et al. TGF beta signals through a heteromeric protein kinase receptor complex. Cell 1992, 71:1003-1014.
4. Yamashita H., ten Dijke P., Franzen P., Miyazono K., Heldin C.H. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta. J Biol Chem 1994, 269:20172-20178.
5. Brown K.A., Pietenpol J.A., Moses H.L. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J Cell Biochem 2007, 101:9-33.
6. Zhang Y.E. Non-Smad pathways in TGF-beta signaling. Cell Res 2009, 19:128-139.
7. Koesters R., Kaissling B., Lehir M., Picard N., Theilig F., Gebhardt R., et al. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 2010, 177:632-643.
8. Miyajima A., Chen J., Lawrence C., Ledbetter S., Soslow R.A., Stern J., et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 2000, 58:2301-2313.
9. Desmouliere A., Geinoz A., Gabbiani F., Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993, 122:103-111.
10. Ignotz R.A., Endo T., Massague J. Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem 1987, 262:6443-6446.
11. Roberts A.B., Sporn M.B., Assoian R.K., Smith J.M., Roche N.S., Wakefield L.M., et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 1986, 83:4167-4171.
12. Edwards D.R., Murphy G., Reynolds J.J., Whitham S.E., Docherty A.J., Angel P., et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987, 6:1899-1904.
13. Leco K.J., Khokha R., Pavloff N., Hawkes S.P., Edwards D.R. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol Chem 1994, 269:9352-9360.
14. Tang N., Cunningham K., Enger M.D. TGF beta elicits opposite responses in clonal subpopulations of NRK-49F cells. Exp Cell Res 1991, 196:13-19.
15. Alvarez R.J., Sun M.J., Haverty T.P., Iozzo R.V., Myers J.C., Neilson E.G. Biosynthetic and proliferative characteristics of tubulointerstitial fibroblasts probed with paracrine cytokines. Kidney Int 1992, 41:14-23.
16. Uttamsingh S., Bao X., Nguyen K.T., Bhanot M., Gong J., Chan J.L., et al. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 2008, 27:2626-2634.
17. Wang S., Wilkes M.C., Leof E.B., Hirschberg R. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo. FASEB J 2005, 19:1-11.
18. Runyan C.E., Schnaper H.W., Poncelet A.C. The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem 2004, 279:2632-2639.
19. Runyan C.E., Schnaper H.W., Poncelet A.C. Smad3 and PKCdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells. Am J Physiol Renal Physiol 2003, 285:F413-F422.
20. Hayashida T., Poncelet A.C., Hubchak S.C., Schnaper H.W. TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int 1999, 56:1710-1720.
21. Basile D.P., Rovak J.M., Martin D.R., Hammerman M.R. Increased transforming growth factor-beta 1 expression in regenerating rat renal tubules following ischemic injury. Am J Physiol 1996, 270:F500-F509.
22. Sutaria P.M., Ohebshalom M., McCaffrey T.A., Vaughan E.D., Felsen D. Transforming growth factor-beta receptor types I and II are expressed in renal tubules and are increased after chronic unilateral ureteral obstruction. Life Sci 1998, 62:1965-1972.
23. Goumenos D.S., Tsakas S., El Nahas A.M., Alexandri S., Oldroyd S., Kalliakmani P., et al. Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria. Nephrol Dial Transplant 2002, 17:2145-2152.
24. Yoshikawa M., Hishikawa K., Idei M., Fujita T. Trichostatin a prevents TGF-beta1-induced apoptosis by inhibiting ERK activation in human renal tubular epithelial cells. Eur J Pharmacol 2010, 642:28-36.
25. Lee C.G., Cho S.J., Kang M.J., Chapoval S.P., Lee P.J., Noble P.W., et al. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med 2004, 200:377-389.
26. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998, 101:890-898.
27. Bottinger E.P., Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol 2002, 13:2600-2610.
28. Li Y., Yang J., Dai C., Wu C., Liu Y. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 2003, 112:503-516.
29. Masszi A., Fan L., Rosivall L., McCulloch C.A., Rotstein O.D., Mucsi I., et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition: role for beta-catenin. Am J Pathol 2004, 165:1955-1967.
30. Masszi A., Di Ciano C., Sirokmany G., Arthur W.T., Rotstein O.D., Wang J., et al. Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol 2003, 284:F911-F924.
31. Yang J., Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001, 159:1465-1475.
32. Strutz F., Zeisberg M., Ziyadeh F.N., Yang C.Q., Kalluri R., Muller G.A., et al. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 2002, 61:1714-1728.
33. Sato M., Muragaki Y., Saika S., Roberts A.B., Ooshima A. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 2003, 112:1486-1494.
34. Zeisberg M., Duffield J.S. Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 2010, 21:1247-1253.
35. Kriz W., Kaissling B., Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?. J Clin Invest 2011, 121:468-474.
36. Van Obberghen-Schilling E., Roche N.S., Flanders K.C., Sporn M.B., Roberts A.B. Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J Biol Chem 1988, 263:7741-7746.
37. Zhang M., Fraser D., Phillips A. ERK, p38, and Smad signaling pathways differentially regulate transforming growth factor-beta1 autoinduction in proximal tubular epithelial cells. Am J Pathol 2006, 169:1282-1293.
38. Krag S., Danielsen C.C., Carmeliet P., Nyengaard J., Wogensen L. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease. Kidney Int 2005, 68:2651-2666.
39. Oda T., Jung Y.O., Kim H.S., Cai X., Lopez-Guisa J.M., Ikeda Y., et al. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 2001, 60:587-596.
40. Naim R., Naumann A., Barnes J., Sauter A., Hormann K., Merkel D., et al. Transforming growth factor-beta1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture. Aesthetic Plast Surg 2008, 32:346-352.
41. Gardner S., Alzhanov D., Knollman P., Kuninger D., Rotwein P. TGF-beta inhibits muscle differentiation by blocking autocrine signaling pathways initiated by IGF-II. Mol Endocrinol 2011, 25:128-137.
42. Yang Z., Mu Z., Dabovic B., Jurukovski V., Yu D., Sung J., et al. Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J Cell Biol 2007, 176:787-793.
43. Ma L.J., Yang H., Gaspert A., Carlesso G., Barty M.M., Davidson J.M., et al. Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice. Am J Pathol 2003, 163:1261-1273.
44. Jenkins R.G., Su X., Su G., Scotton C.J., Camerer E., Laurent G.J., et al. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 2006, 116:1606-1614.
45. Munger J.S., Huang X., Kawakatsu H., Griffiths M.J., Dalton S.L., Wu J., et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999, 96:319-328.
46. Annes J.P., Chen Y., Munger J.S., Rifkin D.B. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol 2004, 165:723-734.
47. Keski-Oja J., Koli K., von Melchner H. TGF-beta activation by traction?. Trends Cell Biol 2004, 14:657-659.
48. Essig M., Terzi F., Burtin M., Friedlander G. Mechanical strains induced by tubular flow affect the phenotype of proximal tubular cells. Am J Physiol Renal Physiol 2001, 281:F751-F762.
49. Ying W.Z., Sanders P.W. Dietary salt modulates renal production of transforming growth factor-beta in rats. Am J Physiol 1998, 274:F635-F641.
50. Rohatgi R., Flores D. Intratubular hydrodynamic forces influence tubulointerstitial fibrosis in the kidney. Curr Opin Nephrol Hypertens 2010, 19:65-71.
51. Gewin L., Bulus N., Mernaugh G., Moeckel G., Harris R.C., Moses H.L., et al. TGF-beta receptor deletion in the renal collecting system exacerbates fibrosis. J Am Soc Nephrol 2010, 21:1334-1343.
52. Morris D.G., Huang X., Kaminski N., Wang Y., Shapiro S.D., Dolganov G., et al. Loss of integrin alpha(v)beta6-mediated TGF-beta activation causes Mmp12-dependent emphysema. Nature 2003, 422:169-173.
53. Bottinger E.P., Jakubczak J.L., Roberts I.S., Mumy M., Hemmati P., Bagnall K., et al. Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas. EMBO J 1997, 16:2621-2633.
54. Ferenbach D., Kluth D.C., Hughes J. Inflammatory cells in renal injury and repair. Semin Nephrol 2007, 27:250-259.
55. Sean Eardley K., Cockwell P. Macrophages and progressive tubulointerstitial disease. Kidney Int 2005, 68:437-455.
56. Zhang X.L., Topley N., Ito T., Phillips A. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. J Biol Chem 2005, 280:12239-12245.
57. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699.
58. Letterio J.J., Roberts A.B. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998, 16:137-161.
59. Kitamura M., Suto T., Yokoo T., Shimizu F., Fine L.G. Transforming growth factor-beta 1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J Immunol 1996, 156:2964-2971.
60. Alexandrow M.G., Moses H.L. Transforming growth factor beta and cell cycle regulation. Cancer Res 1995, 55:1452-1457.
61. Qi W., Chen X., Polhill T.S., Sumual S., Twigg S., Gilbert R.E., et al. TGF-beta1 induces IL-8 and MCP-1 through a connective tissue growth factor-independent pathway. Am J Physiol Renal Physiol 2006, 290:F703-F709.
62. Bohle A., Mackensen-Haen S., Wehrmann M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 1996, 19:191-195.
63. Kimura K., Iwano M., Higgins D.F., Yamaguchi Y., Nakatani K., Harada K., et al. Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 2008, 295:F1023-F1029.
64. Sanders P.W. Vascular consequences of dietary salt intake. Am J Physiol Renal Physiol 2009, 297:F237-F243.
65. Jing L., Zhang J.Z., Zhao L., Wang Y.L., Guo F.Y. High-expression of transforming growth factor beta1 and phosphorylation of extracellular signal-regulated protein kinase in vascular smooth muscle cells from aorta and renal arterioles of spontaneous hypertension rats. Clin Exp Hypertens 2007, 29:107-117.
66. Rouschop K.M., Claessen N., Pals S.T., Weening J.J., Florquin S. CD44 disruption prevents degeneration of the capillary network in obstructive nephropathy via reduction of TGF-beta1-induced apoptosis. J Am Soc Nephrol 2006, 17:746-753.
67. Zeisberg E.M., Potenta S.E., Sugimoto H., Zeisberg M., Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008, 19:2282-2287.
68. Pepper M.S., Belin D., Montesano R., Orci L., Vassalli J.D. Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 1990, 111:743-755.
69. Nakagawa T., Li J.H., Garcia G., Mu W., Piek E., Bottinger E.P., et al. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways. Kidney Int 2004, 66:605-613.
70. Kang D.H., Anderson S., Kim Y.G., Mazzalli M., Suga S., Jefferson J.A., et al. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 2001, 37:601-611.
71. Kang D.H., Hughes J., Mazzali M., Schreiner G.F., Johnson R.J. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 2001, 12:1448-1457.
72. Spurgeon K.R., Donohoe D.L., Basile D.P. Transforming growth factor-beta in acute renal failure: receptor expression, effects on proliferation, cellularity, and vascularization after recovery from injury. Am J Physiol Renal Physiol 2005, 288:F568-F577.
73. Saxena V., Lienesch D.W., Zhou M., Bommireddy R., Azhar M., Doetschman T., et al. Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage. J Immunol 2008, 180:1903-1912.
74. Cao Q., Wang Y., Zheng D., Sun Y., Lee V.W., Zheng G., et al. IL-10/TGF-beta-modified macrophages induce regulatory T cells and protect against adriamycin nephrosis. J Am Soc Nephrol 2010, 21:933-942.
75. Ng Y.Y., Hou C.C., Wang W., Huang X.R., Lan H.Y. Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. Kidney Int Suppl 2005, 94:S83-S91.
76. Chen H.Y., Huang X.R., Wang W., Li J.H., Heuchel R.L., Chung A.C., et al. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential. Diabetes 2011, 60:590-601.
77. Wang W., Huang X.R., Li A.G., Liu F., Li J.H., Truong L.D., et al. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol 2005, 16:1371-1383.
78. Nath K.A., Croatt A.J., Warner G.M., Grande J.P. Genetic deficiency of Smad3 protects against murine ischemic acute kidney injury. Am J Physiol Renal Physiol 2011, 301:F436-F442.
79. Meng X., Huang X.R., Xiao J., Chung A.C., Qin W., Chen H.Y., et al. Disruption of Smad4 impairs TGF-beta/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. Kidney Int 2011.
80. Prakash J., de Borst M.H., van Loenen-Weemaes A.M., Lacombe M., Opdam F., van Goor H., et al. Cell-specific delivery of a transforming growth factor-beta type I receptor kinase inhibitor to proximal tubular cells for the treatment of renal fibrosis. Pharm Res 2008, 10:2427-2439.
81. Leveen P., Larsson J., Ehinger M., Cilio C.M., Sundler M., Sjostrand L.J., et al. Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood 2002, 100:560-568.